In 2024, the global use of contraceptive methods among women reached ** percent, yet varied greatly from one region of the world to another. Only ** percent of women aged 15 to 49 years used a contraceptive method in West and Central Africa. Contraceptive use was consistently higher in married women. In 2024, the global use of contraceptive methods among married women, aged 15 to 49 years old, reached ** percent.

A 2021 survey of American high school students found that of those who were sexually active and engaging in sex with opposite-sex partners, 20.9 percent were using the birth control pill to prevent pregnancy. Prevalence was highest among female students.

Central African Republic CF: Contraceptive Prevalence: Any Methods: % of Women Aged 15-49 data was reported at 17.800 % in 2019. This records an increase from the previous number of 15.180 % for 2010. Central African Republic CF: Contraceptive Prevalence: Any Methods: % of Women Aged 15-49 data is updated yearly, averaging 17.800 % from Dec 1995 (Median) to 2019, with 5 observations. The data reached an all-time high of 27.943 % in 2000 and a record low of 14.800 % in 1995. Central African Republic CF: Contraceptive Prevalence: Any Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Central African Republic – Table CF.World Bank.WDI: Social: Health Statistics. Contraceptive prevalence, any method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, any method of contraception (modern or traditional). Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception. Traditional methods of contraception include rhythm (e.g., fertility awareness based methods, periodic abstinence), withdrawal and other traditional methods.;Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division (World Contraceptive Use 2024).;Weighted average;

Contraception methods in the United States reveal a diverse landscape of choices, with male condoms and oral contraceptives leading the way. A 2024 survey found that 25 percent of reproductive-aged women used male condoms in the past year, while 22 percent opted for oral contraceptives. This data highlights the continued importance of accessible and varied contraceptive options for American women. Increasing contraception use and pregnancy prevention The use of contraception among sexually active women in the U.S. has seen a significant increase in recent years. In 2022, approximately 65 percent of women who had sex in the past year reported using at least one method of contraception, up from less than half in 2017. Although there are various reasons to use contraception, avoiding pregnancy is the most common reason, with 65 percent of women in 2024 reporting using contraception solely to prevent pregnancy. The importance of pregnancy prevention is further emphasized by the fact that about 74 percent of reproductive-aged women in 2022 considered it very or somewhat important to avoid pregnancy in the next month. Challenges and side effects Despite the widespread use of contraception, women face various challenges in maintaining consistent use and managing side effects. For example, approximately one-third of women of reproductive age who used hormonal contraception reported missing a dose due to supply problems. Additionally, side effects remain a significant concern for many users. In 2022, almost half of women using contraception experienced mood changes and weight gain as the most common side effects. Nearly eight out of ten women reported experiencing two or more side effects that were either unexpected or more severe than anticipated, underscoring the need for improved education and support for contraceptive users.

ABSTRACT Objective: To verify the association between Social Determinants of Health and birth control methods used by women of childbearing age. Methods: Documentary and retrospective study, performed at a Brazilian Natural Birth Center with evaluation of the medical records of patients seen between 2003 and 2011 (n=2410). Data were collected on identification and general history, gynecological, sexual and obstetric. Results: Hormone birth control methods were the most used among participants (25.0%); followed by barrier methods (21.5%) and surgical methods (19.3%). Statistical associations were observed regarding age, menarche, onset of sexual activity, pregnancy, miscarriage, smoking, hypertension, marital status, gynecological care and schooling with the choice of methods. Conclusion: The results confirm the importance of studies involving Social Determinants of Health, since they interfere in the way women choose birth control methods and the risks that this choice may pose to their health.

Guyana GY: Contraceptive Prevalence: Any Methods: % of Women Aged 15-49 data was reported at 33.900 % in 2014. This records a decrease from the previous number of 42.500 % for 2009. Guyana GY: Contraceptive Prevalence: Any Methods: % of Women Aged 15-49 data is updated yearly, averaging 34.600 % from Dec 1975 (Median) to 2014, with 7 observations. The data reached an all-time high of 42.500 % in 2009 and a record low of 29.500 % in 1975. Guyana GY: Contraceptive Prevalence: Any Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Guyana – Table GY.World Bank: Health Statistics. Contraceptive prevalence rate is the percentage of women who are practicing, or whose sexual partners are practicing, any form of contraception. It is usually measured for women ages 15-49 who are married or in union.; ; UNICEF's State of the World's Children and Childinfo, United Nations Population Division's World Contraceptive Use, household surveys including Demographic and Health Surveys and Multiple Indicator Cluster Surveys.; Weighted average; Contraceptive prevalence amongst women of reproductive age is an indicator of women's empowerment and is related to maternal health, HIV/AIDS, and gender equality.

Philippines PH: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data was reported at 37.600 % in 2013. This records an increase from the previous number of 36.800 % for 2011. Philippines PH: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data is updated yearly, averaging 33.100 % from Dec 1978 (Median) to 2013, with 17 observations. The data reached an all-time high of 37.600 % in 2013 and a record low of 16.200 % in 1978. Philippines PH: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Philippines – Table PH.World Bank.WDI: Health Statistics. Contraceptive prevalence rate is the percentage of women who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. It is usually measured for women ages 15-49 who are married or in union. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.; ; Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.; Weighted average;

A survey of college students in the United States from the fall of 2024 found that the most common method of birth control among college students is the male condom, followed by birth control pills, and the withdrawal method. At that time, about ** percent of college students in the U.S. reported they used a male condom to prevent pregnancy the last time they had vaginal intercourse, while ** percent used birth control pills. Contraception among women in the United States Similarly to college students, male condoms and oral contraceptives are the most common forms of contraception among all adult women in the United States. As of 2024, around ** percent of women of reproductive age in the United States had used male condoms in the past year, while ** percent had used oral contraceptives. These forms of contraception are more common among women aged 18 to 25 years, while the intrauterine device (IUD) is more common among women aged 26 to 35 years than any other age group. The number one reason U.S. women use contraception is to avoid pregnancy. Condom use among high school students In 2023, around ** percent of high school students in the United States reported using a condom during their last sexual intercourse. The share of U.S. high school students who reported using a condom during their last sexual intercourse has deceased over the last decade, with around ** percent reporting condom use in 2013. In 2023, Hispanic high school students were the most likely to have used a condom the last time they had sex, while Asian students were least likely to have used a condom. However, every race/ethnicity saw decreases in condom use from 2013 to 2023.

According to a survey conducted among heterosexual women in Southeast Asia in 2023, almost 70 percent of the respondents in both Singapore and Indonesia had not used any contraceptive method before. In contrast, the share of respondents who had not used contraception before amounted to 31 percent in Thailand.

Snapshot img

Female Contraceptive Market Size 2024-2028

The female contraceptive market size is forecast to increase by USD 4.57 billion at a CAGR of 4.6% between 2023 and 2028. The market is experiencing significant growth due to several key factors. One trend is the increasing preference for contemporary contraceptive methods among teenagers and young populations, aiming to reduce unplanned pregnancies. Married women also continue to seek reliable and effective birth control options, leading to the popularity of various methods such as birth control pill, intrauterine devices (IUDs), and condoms. IUDs, in particular, have gained traction due to their long-term effectiveness and convenience. Hormonal IUDs and nonhormonal IUDs offer different advantages, with hormonal IUDs providing continuous hormonal release and nonhormonal IUDs offering a hormone-free alternative. However, there are challenges to address, such as irregularities in sex education in developed countries, which may result in misconceptions and incorrect usage of contraceptives. Additionally, surgery-related procedures for IUD insertion may deter some individuals from adopting this method. Overall, the market is driven by the need for effective and convenient contraceptive solutions for women.

Request Free Sample

The market is a significant sector within the healthcare industry, catering to the reproductive health needs of a substantial portion of the global female population. The market encompasses a diverse range of products, including intrauterine devices (IUDs), oral contraceptives, transdermal patches, vaginal gels, contraceptive injections, spermicides, female condoms, diaphragms and caps, and various other medications. The demand for contemporary contraceptives continues to grow as more women seek reliable and effective methods to prevent unplanned pregnancies. According to recent studies, the young population and teenagers represent a substantial portion of this demand.

Furthermore, the contraceptive pipeline is rich with new developments. For instance, dienogest + ethinylestradiol and Estelle (drospirenone + estetrol) are two promising oral contraceptives undergoing clinical trials. Dienogest, a progestogen, is known for its unique mechanism of action, while Estelle's novel estetrol component sets it apart from traditional oral contraceptives. Female population segments with specific health concerns, such as vitiligo patients and those at risk for osteoporosis, also contribute to the market's growth. These women require contraceptive solutions that cater to their unique health needs. The success of oral contraceptives has led to the exploration of alternative delivery methods.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD Billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Distribution Channel

  Offline
  Online


Product

  Female contraceptive devices
  Female contraceptive drugs


Geography

  North America

    Canada
    US


  Europe

    France


  APAC

    China
    Japan


  South America



  Middle East and Africa

By Distribution Channel Insights

The offline segment is estimated to witness significant growth during the forecast period. The market encompasses various products such as Male Condoms, Vaginal Rings, Subdermal Implants, Tablets (Oral Contraceptive Pills), Injectables, and more. These offerings are available through multiple channels, including Households, Clinics, and Hospitals. The market for female contraceptives is experiencing steady growth due to the increasing unmet needs and gender-based barriers to accessing contraceptives. Unintended pregnancies continue to be a concern, making the demand for effective and reliable contraceptive methods high. Major merchandisers, including specialty stores, supermarkets, and department stores, play a significant role in the distribution of these products. These merchandisers offer a wide range of brands and types of female contraceptives, contributing to the market's growth.

Additionally, they are expanding their reach to local and regional markets to cater to the increasing demand. Furthermore, there is a growing trend towards the development of male contraceptive methods. However, the market for male contraceptives is currently in its nascent stages, presenting significant opportunities for growth. As awareness about sexual and reproductive health continues to increase, the demand for effective and accessible contraceptive options is expected to rise.

Get a glance at the market share of various segments Request Free Sample

The Offline segment was valued at USD 10.45 billion in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 37% to the growth of

In 2022, roughly a third of women of reproductive age in the U.S. that ever used hormonal contraception said they had missed taking their birth control on time at some point because they were unable to get their next supply. This statistic illustrates the percentage of contraceptive-using women in the U.S. who had missed taking their birth control due to a lack of supply as of 2022, by age.

Lesotho LS: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data was reported at 59.800 % in 2014. This records an increase from the previous number of 45.600 % for 2010. Lesotho LS: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data is updated yearly, averaging 35.200 % from Dec 1977 (Median) to 2014, with 11 observations. The data reached an all-time high of 59.800 % in 2014 and a record low of 3.400 % in 1977. Lesotho LS: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Lesotho – Table LS.World Bank: Health Statistics. Contraceptive prevalence rate is the percentage of women who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. It is usually measured for women ages 15-49 who are married or in union. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.; ; Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.; Weighted Average;

Hong Kong HK: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data was reported at 71.900 % in 2012. This records a decrease from the previous number of 75.400 % for 2007. Hong Kong HK: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data is updated yearly, averaging 75.000 % from Dec 1972 (Median) to 2012, with 9 observations. The data reached an all-time high of 81.300 % in 2002 and a record low of 43.300 % in 1972. Hong Kong HK: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Hong Kong SAR – Table HK.World Bank.WDI: Health Statistics. Contraceptive prevalence rate is the percentage of women who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. It is usually measured for women ages 15-49 who are married or in union. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.; ; Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.; Weighted average;

Comprehensive dataset of 11 Birth control centers in Virginia, United States as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 82 Birth control centers in Illinois, United States as of June, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 13 Birth control centers in Michigan, United States as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 11 Birth control centers in Oregon, United States as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Comprehensive dataset of 27 Birth control centers in Pennsylvania, United States as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

Gabon GA: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data was reported at 19.400 % in 2012. This records an increase from the previous number of 13.400 % for 2000. Gabon GA: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data is updated yearly, averaging 16.400 % from Dec 2000 (Median) to 2012, with 2 observations. The data reached an all-time high of 19.400 % in 2012 and a record low of 13.400 % in 2000. Gabon GA: Contraceptive Prevalence: Modern Methods: % of Women Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Gabon – Table GA.World Bank: Health Statistics. Contraceptive prevalence rate is the percentage of women who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. It is usually measured for women ages 15-49 who are married or in union. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.; ; Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.; Weighted average;

I’d like to request data on the number of prescriptions for the contraceptive pill in the UK over the past 5 years 2019 – 2023. I would like this data broken down year by year. Response Under Section 21 of the Act, we are not required to provide information in response to a request if it is already reasonably accessible to you. There is Prescription Cost Analysis (PCA) monthly administrative data published in the Open Data Portal that includes contraceptive prescriptions items dispensed in the community in England on a monthly basis and submitted to the NHSBSA for reimbursement. These files can be filtered by product name to locate the information you require: Prescription cost analysis (PCA) contains information on all prescription items dispensed in England and submitted to the NHSBSA for reimbursement: https://opendata.nhsbsa.net/dataset/prescription-cost-analysis-pca-annual-statistics The English prescribing dataset (EPD) contains information on prescriptions issued in England that have been dispensed in England, Wales, Scotland, Guernsey, Alderney, Jersey, and the Isle of Man. https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd On the Prescription Cost Analysis (PCA) Monthly Administrative Data page scroll down to Data and Resources and find the month required. Click the explore button. Then click Preview (to download only contraceptive data) rather than the entire (all BNF Sections) dataset. Use the Add Filter button and choose BNF_SECTIONs Contraceptive Devices and Contraceptives. The data includes items, total quantity, and NIC. There is a Data Dictionary describing each column of data (once you select a time period at the bottom of the screen). Go to the Data Explorer options and select Download filtered records. You will need this for each month required. Please note, that to obtain the figures for contraceptive prescriptions, you will need to add a filter for the BNF_SECTIONs Contraceptive Devices and Contraceptives. The data includes items, total quantity and NIC. There is a Data Dictionary describing each column of data once you select a time period (at the bottom of the screen). To view a video on how to use the Open Data Portal: https://www.youtube.com/watch?v=JNC1EQJAPNY